Safety of Anti-Immunoglobulin E Therapy With Omalizumab in Allergic Patients at Risk of Geohelminth Infection

Clinical and Experimental Allergy - United Kingdom
doi 10.1111/j.1365-2222.2007.02650.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley


Related search